ADZYNMA
Live / Registered — Registered (as of 16 Apr 2024)
What this means for you
Registered since 16 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97587783
- Registration number
- 7358135
- Mark type
- Stylized text
- Filed
- 12 Sept 2022
- Published for opposition
- 30 Jan 2024
- Registered
- 16 Apr 2024
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, enzyme replacement therapy for thrombotic disorders
Owner
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
Prosecution history
- 16 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 30 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jan 2024 — PUBLISHED FOR OPPOSITION
- 10 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Dec 2023 — EXAMINER'S AMENDMENT ENTERED
- 22 Dec 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Dec 2023 — EXAMINERS AMENDMENT E-MAILED
- 22 Dec 2023 — EXAMINERS AMENDMENT -WRITTEN
- 14 Dec 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 13 Dec 2023 — USE AMENDMENT ACCEPTED
- 13 Dec 2023 — AMENDMENT TO USE PROCESSING COMPLETE
- 13 Dec 2023 — USE AMENDMENT FILED
- 12 Dec 2023 — TEAS AMENDMENT OF USE RECEIVED